Jump to content
Sclero Forums
Sign in to follow this  
Joelf

Rituximab (RTX) in primary Sjögren's (pSS) syndrome: a ten-year journey.

Recommended Posts

Rituximab (RTX) in primary Sjögren's (pSS) syndrome: a ten-year journey.

 

The good results observed after RTX treatment in pSS should represent the starting point to develop evidence-based guidelines for the use of biologic therapy in this disease. PubMed, Lupus, 2014 Aug 5. (Also see: Sjogren's Syndrome Treatments)

 

This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.


Jo Frowde

ISN Assistant Webmaster

SD World Webmaster

ISN Sclero Forums Manager

ISN News Manager

ISN Hotline Support Specialist

International Scleroderma Network (ISN)

Share this post


Link to post
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
Sign in to follow this  

×